Navigation Links
ISTA Pharmaceuticals to Present at the Bank of America 2008 Health Care Conference
Date:5/6/2008

IRVINE, Calif., May 6 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced it will present at the Bank of America 2008 Health Care Conference at 2:40 p.m. Pacific Daylight Time on May 13, 2008, at the Four Seasons in Las Vegas, NV.

ISTA's President and Chief Executive Officer, Vicente Anido, Jr., Ph.D., will provide an update on the Company's commercial and clinical progress. To access the live audio broadcast or the subsequent archived recording log onto http://www.istavision.com. Please connect to the website several minutes prior to the start of the conference call to ensure adequate time for any software download that may be necessary.

ABOUT ISTA PHARMACEUTICALS

ISTA Pharmaceuticals is an ophthalmic pharmaceutical company. ISTA's products and product candidates addressing the $4.7 billion U.S. prescription ophthalmic industry include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. The Company currently markets three products and is developing a strong product pipeline to fuel future growth and market share. The Company's product development and commercialization strategy is to launch a new product every 12 to 18 months, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' website at http://www.istavision.com.


'/>"/>
SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Alseres Pharmaceuticals, Inc. to Present at The Neurotech Industry Investing & Partnering Conference
2. ADVENTRX Pharmaceuticals to Report First Quarter 2008 Results
3. BioCryst Pharmaceuticals to Announce First Quarter 2008 Financial Results on May 8, 2008
4. Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology Meeting
5. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter Financial Results and Provide a Clinical Program Update on May 6, 2008
6. Arena Pharmaceuticals to Report First Quarter 2008 Financial Results and to Host Conference Call and Webcast on Wednesday, May 7, 2008
7. Arena Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
8. MAP Pharmaceuticals to Present at Upcoming Investor Conferences
9. Agreement Executed for Amneal Pharmaceuticals to Acquire the Assets of Interpharm Holdings
10. Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg
11. Onyx Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... 31, 2016 , ... Secura Consultants is sponsoring the 2016 ... 21-23 at the Spazio Westport. The conference is a three day event focused ... work primarily with physicians and professionals in the medical market. , “Professional development ...
(Date:5/31/2016)... ... May 31, 2016 , ... Joe DiMaggio Children’s ... Florida. , The clinic is led by a world class team of ... pediatric neuropsychology and also a team of certified vestibular therapists. , The ...
(Date:5/31/2016)... ... May 31, 2016 , ... Fire Door ... has joined the Fire Door Solutions’ team. Keith will serve Fire Door ... frame in-field re-labeling. He will be instrumental in developing educational curriculum and ...
(Date:5/31/2016)... ... May 31, 2016 , ... Presence Technology ... has been included by Gartner, Inc. in the Contact Center Infrastructure Magic Quadrant ... Center Infrastructure technologies, some of which include: Computer-telephony integration (CTI)/Web services interfaces, ...
(Date:5/31/2016)... (PRWEB) , ... May 31, 2016 , ... ... using a mix of advanced Artificial Intelligence (AI) and the latest in ... The medical center is integrating predictive analytic outputs directly into the clinical workflow. ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)... Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... for June 7, 2016, to take a closer look at ... 1 p.m. ET, will focus on a man named Jay ... to wellness. The event is the first ... health care professionals, talking about triumphs and the struggles they ...
(Date:5/31/2016)... -- Mundipharma EDO GmbH (Early Development in ... trial of its investigational drug candidate EDO-S101. A first ... developed for the treatment of relapsed-refractory (RR) haematological malignances. ... safety and tolerability of ascending doses of EDO-S101 and ... the United States and Europe ...
(Date:5/31/2016)... -- , Isansys  Lifecare, a new generation digital ... wireless patient monitoring platform, as it ships more systems to ... , Scotland and Norway ... system, launched earlier this year, is now being used in ... This new technology significantly enhances the user experience and ...
Breaking Medicine Technology: